This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Agodi A, Barchitta M, Quattrocchi A, Maugeri A, Aldisio E, Marchese AE, Mattaliano AR, Tsakris A. Antibiotic trends of Klebsiella pneumoniae and Acinetobacter baumannii resistance indicators in an intensive care unit of Southern Italy, 2008–2013. Antimicrob Resist Infect Control. 2015 Dec;4(1):43. doi:10.1186/s13756-015-0087-y MedlineAgodiABarchittaMQuattrocchiAMaugeriAAldisioEMarcheseAEMattalianoARTsakrisAAntibiotic trends of Klebsiella pneumoniae and Acinetobacter baumannii resistance indicators in an intensive care unit of Southern Italy, 2008–2013. Antimicrob Resist Infect Control. 2015Dec;4(1):43. doi:10.1186/s13756-015-0087-yMedlineOpen DOISearch in Google Scholar
Blair JMA, Richmond GE, Piddock LJV. Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance. Future Microbiol. 2014 Oct;9(10):1165–1177. doi:10.2217/fmb.14.66 MedlineBlairJMARichmondGEPiddockLJVMultidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance. Future Microbiol. 2014Oct;9(10):1165–1177. doi:10.2217/fmb.14.66MedlineOpen DOISearch in Google Scholar
Chung J, Bhat A, Kim C, Yong D, Ryu C. Combination therapy with polymyxin B and netropsin against clinical isolates of multidrug-resistant Acinetobacter baumannii. Sci. Rep.-UK. 2016;6:28168.ChungJBhatAKimCYongDRyuCCombination therapy with polymyxin B and netropsin against clinical isolates of multidrug-resistant Acinetobacter baumannii. Sci. Rep.-UK.2016;6:28168.Search in Google Scholar
CLSI. Performance Standards for Antimicrobial Susceptibility Testing. Wayne (USA): Clinical Laboratory Standards Institute; 2017.CLSIPerformance Standards for Antimicrobial Susceptibility Testing. Wayne (USA): Clinical Laboratory Standards Institute; 2017.Search in Google Scholar
Hoffman SJ, Outterson K, Røttingen JA, Cars O, Clift C, Rizvi Z, Rotberg F, Tomson G, Zorzet A. An international legal framework to address antimicrobial resistance. Bull World Health Organ. 2015 Feb 01;93(2):66–66. doi:10.2471/BLT.15.152710 MedlineHoffmanSJOuttersonKRøttingenJACarsOCliftCRizviZRotbergFTomsonGZorzetAAn international legal framework to address antimicrobial resistance. Bull World Health Organ. 2015Feb 01;93(2):66–66. doi:10.2471/BLT.15.152710MedlineOpen DOISearch in Google Scholar
Holbrook SYL, Garneau-Tsodikova S. Evaluation of aminoglycoside and carbapenem resistance in a collection of drug-resistant Pseudomonas aeruginosa clinical isolates. Microb Drug Resist. 2018 Sep;24(7):1020–1030. doi:10.1089/mdr.2017.0101 MedlineHolbrookSYLGarneau-TsodikovaSEvaluation of aminoglycoside and carbapenem resistance in a collection of drug-resistant Pseudomonas aeruginosa clinical isolates. Microb Drug Resist. 2018Sep;24(7):1020–1030. doi:10.1089/mdr.2017.0101MedlineOpen DOISearch in Google Scholar
Holden MTG, Feil EJ, Lindsay JA, Peacock SJ, Day NPJ, Enright MC, Foster TJ, Moore CE, Hurst L, Atkin R, et al. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci USA. 2004 Jun 29;101(26):9786–9791. doi:10.1073/pnas.0402521101 MedlineHoldenMTGFeilEJLindsayJAPeacockSJDayNPJEnrightMCFosterTJMooreCEHurstLAtkinRet alComplete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci USA. 2004Jun 29;101(26):9786–9791. doi:10.1073/pnas.0402521101MedlineOpen DOISearch in Google Scholar
Hu FP, Guo Y, Zhu DM, Wang F, Jiang XF, Xu YC, Zhang XJ, Zhang CX, Ji P, Xie Y. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005–2014. Clin. Microbiol. Infec. 2016;22:S9–S14.HuFPGuoYZhuDMWangFJiangXFXuYCZhangXJZhangCXJiPXieYResistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005–2014. Clin. Microbiol. Infec. 2016;22:S9–S14.10.1016/j.cmi.2016.01.001Search in Google Scholar
Ito T, Katayama Y, Asada K, Mori N, Tsutsumimoto K, Tiensasitorn C, Hiramatsu K. Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2001 May 01;45(5):1323–1336. doi:10.1128/AAC.45.5.1323-1336.2001 MedlineItoTKatayamaYAsadaKMoriNTsutsumimotoKTiensasitornCHiramatsuKStructural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2001May 01;45(5):1323–1336. doi:10.1128/AAC.45.5.1323-1336.2001MedlineOpen DOISearch in Google Scholar
Khan ER, Aung MS, Paul SK, Ahmed S, Haque N, Ahamed F, Sarkar SR, Roy S, Rahman MM, Mahmud MC, et al. Prevalence and molecular epidemiology of clinical isolates of Escherichia coli and Klebsiella pneumoniae harboring Extended-Spectrum Beta-Lactamase and carbapenemase genes in Bangladesh. Microb Drug Resist. 2018 Dec;24(10):1568–1579. doi:10.1089/mdr.2018.0063 MedlineKhanERAungMSPaulSKAhmedSHaqueNAhamedFSarkarSRRoySRahmanMMMahmudMCet alPrevalence and molecular epidemiology of clinical isolates of Escherichia coli and Klebsiella pneumoniae harboring Extended-Spectrum Beta-Lactamase and carbapenemase genes in Bangladesh. Microb Drug Resist. 2018Dec;24(10):1568–1579. doi:10.1089/mdr.2018.0063MedlineOpen DOISearch in Google Scholar
Lafaurie M, Porcher R, Donay JL, Touratier S, Molina JM. Reduction of fluoroquinolone use is associated with a decrease in methicillin-resistant Staphylococcus aureus and fluoroquinolone-resistant Pseudomonas aeruginosa isolation rates: a 10 year study. J Antimicrob Chemother. 2012 Apr 01;67(4):1010–1015. doi:10.1093/jac/dkr555 MedlineLafaurieMPorcherRDonayJLTouratierSMolinaJMReduction of fluoroquinolone use is associated with a decrease in methicillin-resistant Staphylococcus aureus and fluoroquinolone-resistant Pseudomonas aeruginosa isolation rates: a 10 year study. J Antimicrob Chemother. 2012Apr 01;67(4):1010–1015. doi:10.1093/jac/dkr555MedlineOpen DOISearch in Google Scholar
Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, Doi Y, Tian G, Dong B, Huang X, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016 Feb;16(2):161–168. doi:10.1016/S1473-3099(15)00424-7 MedlineLiuYYWangYWalshTRYiLXZhangRSpencerJDoiYTianGDongBHuangXet alEmergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016Feb;16(2):161–168. doi:10.1016/S1473-3099(15)00424-7MedlineOpen DOISearch in Google Scholar
Livermore DM. Fourteen years in resistance. Int J Antimicrob Agents. 2012 Apr;39(4):283–294. doi:10.1016/j.ijantimicag.2011.12.012 MedlineLivermoreDMFourteen years in resistance. Int J Antimicrob Agents. 2012Apr;39(4):283–294. doi:10.1016/j.ijantimicag.2011.12.012Medline22386741Open DOISearch in Google Scholar
Michael CA, Dominey-Howes D, Labbate M. The antimicrobial resistance crisis: causes, consequences, and management. Front Public Health. 2014 Sep 16;2:145. doi:10.3389/fpubh.2014.00145 MedlineMichaelCADominey-HowesDLabbateMThe antimicrobial resistance crisis: causes, consequences, and management. Front Public Health. 2014Sep 16;2:145. doi:10.3389/fpubh.2014.00145Medline416512825279369Open DOISearch in Google Scholar
Olufunmiso O, Tolulope I, Roger C. Multidrug and vancomycin resistance among clinical isolates of Staphylococcus aureus from different teaching hospitals in Nigeria. Afr Health Sci. 2017 Sep 18;17(3):797–807. doi:10.4314/ahs.v17i3.23 MedlineOlufunmisoOTolulopeIRogerCMultidrug and vancomycin resistance among clinical isolates of Staphylococcus aureus from different teaching hospitals in Nigeria. Afr Health Sci. 2017Sep 18;17(3):797–807. doi:10.4314/ahs.v17i3.23Medline565620429085408Open DOISearch in Google Scholar
Panesso D, Planet PJ, Diaz L, Hugonnet JE, Tran TT, Narechania A, Munita JM, Rincon S, Carvajal LP, Reyes J, et al. Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, Brazil. Emerg Infect Dis. 2015 Oct;21(10):1844–1848. doi:10.3201/eid2110.141914 MedlinePanessoDPlanetPJDiazLHugonnetJETranTTNarechaniaAMunitaJMRinconSCarvajalLPReyesJet alMethicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, Brazil. Emerg Infect Dis. 2015Oct;21(10):1844–1848. doi:10.3201/eid2110.141914Medline459343026402569Open DOISearch in Google Scholar
Pathak A, Chandran SP, Mahadik K, Macaden R, Lundborg CS. Frequency and factors associated with carriage of multi-drug resistant commensal Escherichia coliamong women attending antenatal clinics in Central India. BMC Infect Dis. 2013 Dec;13(1): 199. doi:10.1186/1471-2334-13-199 MedlinePathakAChandranSPMahadikKMacadenRLundborgCSFrequency and factors associated with carriage of multi-drug resistant commensal Escherichia coliamong women attending antenatal clinics in Central India. BMC Infect Dis. 2013Dec;13(1): 199. doi:10.1186/1471-2334-13-199Medline365590523638834Open DOISearch in Google Scholar
Peneş NO, Muntean AA, Moisoiu A, Muntean MM, Chirca A, Bogdan MA, Popa MI. An overview of resistance profiles ESKAPE pathogens from 2010–2015 in a tertiary respiratory center in Romania. Rom J Morphol Embryol. 2017;58(3):909–922. MedlinePeneşNOMunteanAAMoisoiuAMunteanMMChircaABogdanMAPopaMIAn overview of resistance profiles ESKAPE pathogens from 2010–2015 in a tertiary respiratory center in Romania. Rom J Morphol Embryol. 2017;58(3):909–922. MedlineSearch in Google Scholar
Reale M, Strazzulla A, Quirino A, Rizzo C, Marano V, Postorino MC, Mazzitelli M, Greco G, Pisani V, Costa C, et al. Patterns of multi-drug resistant bacteria at first culture from patients admitted to a third level University hospital in Calabria from 2011 to 2014: implications for empirical therapy and infection control. Infez Med. 2017 Jun 1;25(2):98–107. MedlineRealeMStrazzullaAQuirinoARizzoCMaranoVPostorinoMCMazzitelliMGrecoGPisaniVCostaCet alPatterns of multi-drug resistant bacteria at first culture from patients admitted to a third level University hospital in Calabria from 2011 to 2014: implications for empirical therapy and infection control. Infez Med. 2017Jun 1;25(2):98–107. MedlineSearch in Google Scholar
Rigatto MH, Vieira FJ, Antochevis LC, Behle TF, Lopes NT, Zavascki AP. Polymyxin B in Combination with Antimicrobials Lacking In Vitro Activity versus Polymyxin B in Monotherapy in Critically Ill Patients with Acinetobacter baumannii or Pseudomonas aeruginosa Infections. Antimicrob Agents Chemother. 2015 Oct; 59(10):6575–6580. doi:10.1128/AAC.00494-15 MedlineRigattoMHVieiraFJAntochevisLCBehleTFLopesNTZavasckiAPPolymyxin B in Combination with Antimicrobials Lacking In Vitro Activity versus Polymyxin B in Monotherapy in Critically Ill Patients with Acinetobacter baumannii or Pseudomonas aeruginosa Infections. Antimicrob Agents Chemother. 2015 Oct; 59(10):6575–6580. doi:10.1128/AAC.00494-15Medline457609826259799Open DOISearch in Google Scholar
Rossolini GM, Arena F, Pecile P, Pollini S. Update on the antibiotic resistance crisis. Curr Opin Pharmacol. 2014 Oct;18:56–60. doi:10.1016/j.coph.2014.09.006 MedlineRossoliniGMArenaFPecilePPolliniSUpdate on the antibiotic resistance crisis. Curr Opin Pharmacol. 2014Oct;18:56–60. doi:10.1016/j.coph.2014.09.006Medline25254623Open DOISearch in Google Scholar
Sugawara E, Nikaido H. OmpA is the principal nonspecific slow porin of Acinetobacter baumannii. J Bacteriol. 2012 Aug 01; 194(15):4089–4096. doi:10.1128/JB.00435-12 MedlineSugawaraENikaidoHOmpA is the principal nonspecific slow porin of Acinetobacter baumannii. J Bacteriol. 2012Aug 01; 194(15):4089–4096. doi:10.1128/JB.00435-12Medline341653822636785Open DOISearch in Google Scholar
Tan CK, Tang HJ, Lai CC, Chen YY, Chang PC, Liu WL. Correlation between antibiotic consumption and carbapenem-resistant Acinetobacter baumannii causing health care-associated infections at a hospital from 2005 to 2010. J Microbiol Immunol Infect. 2015 Oct;48(5):540–544. doi:10.1016/j.jmii.2014.02.004 MedlineTanCKTangHJLaiCCChenYYChangPCLiuWLCorrelation between antibiotic consumption and carbapenem-resistant Acinetobacter baumannii causing health care-associated infections at a hospital from 2005 to 2010. J Microbiol Immunol Infect. 2015Oct;48(5):540–544. doi:10.1016/j.jmii.2014.02.004Medline24685280Open DOISearch in Google Scholar
Tang X, Xiao M, Zhuo C, Xu Y, Zhong N. Multi-level analysis of bacteria isolated from inpatients in respiratory departments in China. J Thorac Dis. 2018 May;10(5):2666–2675. doi:10.21037/jtd.2018.04.46 MedlineTangXXiaoMZhuoCXuYZhongNMulti-level analysis of bacteria isolated from inpatients in respiratory departments in China. J Thorac Dis. 2018May;10(5):2666–2675. doi:10.21037/jtd.2018.04.46Medline600607729997928Open DOISearch in Google Scholar
Ventola CL. The antibiotic resistance crisis: part 2: management strategies and new agents. P T. 2015 May;40(5):344–352. MedlineVentolaCLThe antibiotic resistance crisis: part 2: management strategies and new agents. P T. 2015May;40(5):344–352. MedlineSearch in Google Scholar
Vincent JL. Nosocomial infections in adult intensive-care units. Lancet. 2003 Jun;361(9374):2068–2077. doi:10.1016/S0140-6736(03)13644-6 MedlineVincentJLNosocomial infections in adult intensive-care units. Lancet. 2003Jun;361(9374):2068–2077. doi:10.1016/S0140-6736(03)13644-6MedlineOpen DOISearch in Google Scholar
Wang S, Han LZ, Ni YX, Zhang YB, Wang Q, Shi DK, Li WH, Wang YC, Mi CR. Changes in antimicrobial susceptibility of commonly clinically significant isolates before and after the interventions on surgical prophylactic antibiotics (SPAs) in Shanghai. Braz J Microbiol. 2018 Jul;49(3):552–558. doi:10.1016/j.bjm.2017.12.004 MedlineWangSHanLZNiYXZhangYBWangQShiDKLiWHWangYCMiCRChanges in antimicrobial susceptibility of commonly clinically significant isolates before and after the interventions on surgical prophylactic antibiotics (SPAs) in Shanghai. Braz J Microbiol. 2018Jul;49(3):552–558. doi:10.1016/j.bjm.2017.12.004Medline606674429449171Open DOISearch in Google Scholar
Yang Q, Xu YC, Kiratisin P, Dowzicky MJ. Antimicrobial activity among gram-positive and gram-negative organisms collected from the Asia-Pacific region as part of the Tigecycline Evaluation and Surveillance Trial: comparison of 2015 results with previous years. Diagn Microbiol Infect Dis. 2017 Dec;89(4):314–323. doi:10.1016/j.diagmicrobio.2017.08.014 MedlineYangQXuYCKiratisinPDowzickyMJAntimicrobial activity among gram-positive and gram-negative organisms collected from the Asia-Pacific region as part of the Tigecycline Evaluation and Surveillance Trial: comparison of 2015 results with previous years. Diagn Microbiol Infect Dis. 2017Dec;89(4):314–323. doi:10.1016/j.diagmicrobio.2017.08.014Medline28951056Open DOISearch in Google Scholar
Zgurskaya HI, López CA, Gnanakaran S. Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It. ACS Infect Dis. 2015 Nov 13;1(11):512–522. doi:10.1021/acsinfecdis.5b00097 MedlineZgurskayaHILópezCAGnanakaranSPermeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It. ACS Infect Dis. 2015Nov 13;1(11):512–522. doi:10.1021/acsinfecdis.5b00097Medline476499426925460Open DOISearch in Google Scholar
